Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data-Reference-Cited by-同舟云学术

Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data

Published:2017-09-12 Issue:11 Volume:33 Page:1955-1963
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kohsaka Shun¹,Murata Tatsunori²,Izumi Naoko³,Katada Jun³,Wang Feng⁴,Terayama Yasuo⁵

Affiliation:

1. Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;

2. Crecon Medical Assessment Inc., Tokyo, Japan;

3. Pfizer Japan Inc., Tokyo, Japan;

4. Bristol-Myers Squibb Co., NY, USA;

5. Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan

Funder

Bristol-Myers Squibb Co

Pfizer Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1374935

Reference21 articles.

1. Atrial Fibrillation: A Major Contributor to Stroke in the Elderly

2. Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke

3. Management of Patients With Atrial Fibrillation

4. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

5. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study of different doses of rivaroxaban in patients with nonvalvular atrial fibrillation;Medicine;2024-04-26

2. The Role of the Pharmacist in Clinical Settings (13): Estimation of Anticoagulant Activity of an Oral Anticoagulant Based on Patient Data from Nippon Medical School Hospital;Nihon Ika Daigaku Igakkai Zasshi;2024-02-20

3. Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries;Pharmacoepidemiology and Drug Safety;2023-06-21

4. Real-world comparison of in-hospital complications after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database;IJC Heart & Vasculature;2023-02

5. Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis;Intestinal Research;2022-10-31